Not an official event of the 2022 ASCO Annual Meeting.Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®,or Conquer Cancer® the ASCO Foundation.
Saturday, June 04, 2022
6:30 PM – 6:45 PM CT – Registration/Dinner
6:45 PM – 7:45 PM CT – Symposium
Hilton Chicago
720 S Michigan Ave
Chicago, IL 60605
Meeting Room: Waldorf Ballroom (3rd Floor)
PROGRAM FEATURES
- iPads provided to all attendees to enhance learning experience and enable real-time Q&A
- Create your own personalized poster
- Interactive case-based learning environment
- Animated Simulation Treatment Challenge
FACULTY
 |
Alok A. Khorana, MD, FACP, FASCO Professor of Medicine, Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland, OH |
PROGRAM OVERVIEW
This event will focus on the latest updates in the optimal management of cancer-associated venous thromboembolism (VTE) based on risk stratification, clinical trial data, and appropriate guideline-informed strategies to optimize clinical outcomes. This program will inform participants of the latest best practices as recommended by professional guidelines and will equip participants to integrate multidisciplinary care and shared decision-making in practice. An associated online component of this live activity will reinforce application of data in simulated patient case scenarios through an interactive digital program.
TARGET AUDIENCE
This activity is intended for medical oncologists, community oncologists, primary care providers, allied healthcare professionals ie, nurse practitioners, physician assistants, pharmacists, VTE specialists, and/or other healthcare professionals involved in the care of patients with cancer.
LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:
- Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments
- Assess data from clinical trials supporting anticoagulants for the treatment of patients with cancer-associated VTE
- Select appropriate therapies for patients with cancer-associated VTE using recently updated evidence-based guidance from professional organizations
- Optimize outcomes for patients with cancer-associated VTE through adoption of multidisciplinary patient-centered SDM management approaches
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: Education regarding the management of VTE in cancer leads to safe practices, quality care, and continued professional and personal development for oncology nurses. CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For questions, please contact Med Learning Group at [email protected]
Contact this provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.).
Please contact Med Learning Group prior to the live event at [email protected]
